Case Report
Copyright ©The Author(s) 2023.
World J Clin Cases. Oct 6, 2023; 11(28): 6823-6830
Published online Oct 6, 2023. doi: 10.12998/wjcc.v11.i28.6823
Table 1 Cases of pancreatic carcinoma associated with polymyositis and myopathy
Ref.
Sex/age
Statin use
Clinical presentation
Cancer type
Diagnosis
Treatment
Gemcitabine use
Additional findings
Follow-up and outcome
Kida et al[19], 2007M, 53NRArthralgiaAKCTSteroidsNoLate-stageDied 4 yr
Myalgias muscolar weaknessBiopsyFluorouracil radiotherapyCarcinomaAfter diagnosis
Syrios et al[15], 2011M, 52NRWeight lossAKCTSteroidsYes-Remission
Recurrent pancreatitisEMG biopsyGemcitabine erlotinibSix months (then relapse)
Siddiqui et al[20], 2011F, 86NRMuscolar weaknessAKCTSteroidsNo-Remission
BiopsySurgerySix months
Amroun et al[21], 2012M, 47NRAbdominal painAKCTSurgeryYesMyopathyRemission
Jaundice weight loss astheniaMRI BiopsyGemcitabineDeveloped during 4th cycle of chemotherapyNine months, then death due to pneumonia
Padniewski et al[22], 2020M, 66YesGeneralized fatigueAKCTSteroidsYes, later inMyopathyGemcitabine
Muscolar weakness loose stools weight lossMRIFOLFOX followed by gemcitabineCourseDeveloped prior to gemcitabineTrial died 1 mo later
Decraene et al[23], 2021M, 69NRJaundiceNETMRISteroidsNo-Remission
Diarrhea weight lossEMG biopsySurgery carboplatinum-etoposideSix months (no recurrence)
Ozcan et al[24], 2022M, 86YesMyalgiasAKMRISteroidsYes, later inMetastaticThird line
Muscolar weaknessMRCP ERCP biopsySurgery FOLFOX followed by FOLFIRICourseCarcinomaPalliative treatment (gemcitabine and abraxane)
Present case, 2022F, 78YesJaundiceUnknownCTSteroidsNoAKI treated withDied during
Weight loss myalgias muscolar weaknessEMGReplacement therapyHospitalization